scPharmaceuticals Inc. (SCPH)
5.67
0.00 (0.00%)
Inactive · Last trade price on Oct 6, 2025

scPharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
305177225244137145
Upgrade
Market Cap Growth
15.84%-21.22%-7.91%77.80%-4.98%37.04%
Upgrade
Enterprise Value
3161371732107350
Upgrade
Last Close Price
5.673.546.277.175.025.29
Upgrade
PS Ratio
5.894.8816.54---
Upgrade
PB Ratio
-13.306.043.372.431.76
Upgrade
P/TBV Ratio
-13.306.043.372.431.76
Upgrade
EV/Sales Ratio
6.333.7712.74---
Upgrade
Debt / Equity Ratio
-2.463.961.080.520.310.25
Upgrade
Asset Turnover
0.690.360.12---
Upgrade
Inventory Turnover
1.061.000.76---
Upgrade
Quick Ratio
2.965.946.2216.135.0711.28
Upgrade
Current Ratio
3.857.127.0816.635.2711.57
Upgrade
Return on Equity (ROE)
--336.97%-99.97%-57.16%-40.44%-48.24%
Upgrade
Return on Assets (ROA)
-57.08%-40.08%-31.67%-22.24%-17.16%-20.08%
Upgrade
Return on Capital (ROIC)
-101.75%-56.43%-36.97%-24.58%-18.29%-21.41%
Upgrade
Earnings Yield
-30.09%-48.07%-24.38%-15.09%-20.41%-22.29%
Upgrade
FCF Yield
-21.61%-39.83%-26.37%-14.17%-19.78%-19.16%
Upgrade
Buyback Yield / Dilution
-33.47%-15.59%-35.81%-3.68%-11.33%-32.09%
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q